Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

Amputation, one of worse prognostic variables

Original title: Lower Extremity Amputation: Factors Associated With Mortality or Contralateral Amputation Reference: Samir K. Shah, et; al. Vascular and Endovascular Surgery 2013:47 (8):608-613.

Peripheral vascular disease is associated with trophic injuries with tissue lose, often leading to amputation, of which about 50 % were major amputations. 454 amputations in 391 patients were analyzed, 63 were contralateral. Most of the patients have received prior treatment before amputation, which generally was angioplasty procedure.

The amputation rate was 70% transtibial and 30% transfemoral. Mortality at 30 days after amputation was 9.2 %, and after 1, 2 and 5 years revealed 30%, 40% and 56 % respectively, with an average survival of 25.4 months. The variables associated with mortality were age, dialysis, high cardiac risk and transfemoral or transtibial amputation. The need of dialysis and high cardiac risk were associated with contralateral amputation. The only variable that produced protection against death was the contralateral limb intervention. Survival free of contralateral amputation – at 1, 2 and 5 years was 60 %, 49 % and 33 % respectively. The following factors with high risk were associated with contralateral amputation:  Age and moderate or high cardiac risk, having the intervention in that limb a protective effect.

Conclusion

Patients with advanced peripheral vascular disease requiring amputation of one lower limb have a decrease in survival and a high rate of amputation of the contralateral limb. Age and dialysis are factors that predispose to amputation. These data favor the strategies to improve limb preservation. 

Comment

Amputation is associated with poor short-term outcome and increases the risk of repeated in the contralateral limb. It is necessary to optimize medical treatment and education of patients and their relatives in order to prevent or avoid trophic lesions. It is very important before performing angiographic studies or try limb revascularization in the best possible way, once or several times before making the final decision. 

Courtesy of Carlos Fava MD
Interventional Cardiologist
Favaloro Foundation
Argentina

Dr. Carlos Fava para SOLACI.ORG

More articles by this author

SCAI 2026 | Deep vein arterialization as an alternative in patients with critical limb ischemia without conventional options

Critical limb ischemia (CLI) represents one of the most advanced stages of peripheral arterial disease (PAD). In a significant proportion of patients, distal anatomy,...

C-TRACT: Endovascular therapy in post-thrombotic syndrome due to iliac obstruction

Post-thrombotic syndrome (PTS) is one of the most limiting sequelae following proximal deep vein thrombosis (DVT). It clinically manifests as chronic pain, edema, skin...

Coil embolization of segmental arteries as a spinal cord protection strategy prior to complex endovascular repair of thoracoabdominal aorta

Spinal cord ischemia remains one of the most devastating complications in the repair of thoracoabdominal aneurysms, with incidences of up to 20–30% in extensive...

Mechanical thrombectomy versus anticoagulation in intermediate-risk pulmonary embolism: systematic review and meta-analysis

Intermediate-risk pulmonary embolism (PE) has anticoagulation as the standard treatment, while reperfusion strategies remain a matter of debate. In this context, mechanical thrombectomy has...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

HERA-TAVI: Intra-Annular vs Supra-Annular Valves in TAVI

The HERA-TAVI study is an international multicenter registry that compared the clinical and hemodynamic outcomes of contemporary self-expanding transcatheter heart valves with intra-annular (IA)...

DOUBLE-CHOICE: Lower Pacemaker Implantation Rates with ACURATE neo2 Compared with Evolut in Patients Undergoing TAVI

The DOUBLE-CHOICE trial is a multicenter, randomized, controlled study conducted in Germany to evaluate the performance of next-generation transcatheter heart valves and different anesthesia...

GLUCO-TAVI | Can Glucocorticoids Reduce the Need for Permanent Pacemaker Implantation After TAVI?

Despite the expansion of transcatheter aortic valve implantation (TAVI) indications, cardiac conduction disturbances (CCD) and the need for permanent pacemaker implantation (PPI) remain the...